NovoCure Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include Sensei Biotherapeutics.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
Sensei Biotherapeutics
Sensei Biotherapeutics
Sensei Biotherapeutics (formerly known as Panacea Pharmaceuticals) is a biotechnology company developing biologics therapies targeting key components of the immune system for the treatment of cancers.
Founding Date
Founding Date
2018
Founding Date
1999
Type
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Locations
Boston, US HQ
Boston, US
Rockville, US
Employees
Employees
188
Employees
1448% decrease
Valuation ($)
Valuation ($)
243.3 m
Valuation ($)
14.8 m

Financial

Net income
Net income
($274.4m) (FY, 2025)
Net income
($21.1m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Sensei Biotherapeutics
HQ
Boston, US
Employees
14↓ 48% decrease

Sensei Biotherapeutics (formerly known as Panacea Pharmaceuticals) is a biotechnology company developing biologics therapies targeting key components of the immune system for the treatment of cancers.

View company